伽玛刀放射外科治疗纳尔逊综合征:国际多中心研究
OBJECTIVE: Nelson's syndrome is a rare and challenging neuroendocrine disorder, and it is associated with elevated adrenocorticotrophic hormone (ACTH) level, skin hyperpigmentation, and pituitary adenoma growth.…
要点
- 伽玛刀治疗后肿瘤控制率高,多数患者ACTH水平改善。
- 内分泌缓解与切除至伽玛刀间隔较短相关(p=0.039)。
- 垂体功能减退最常见,需长期随访并激素替代。
核心结论
- 伽玛刀放射外科对多数纳尔逊综合征患者可实现高比例垂体腺瘤控制和ACTH水平改善。
主要发现
- 末次随访时影像学肿瘤控制率为92.15%。
- 停用药物情况下内分泌缓解率为29.4%,ACTH水平较治疗前下降者占62.7%。
- 内分泌缓解率提高与切除至伽玛刀治疗时间间隔较短相关(p=0.039)。
- 垂体功能减退发生率为21.6%,新发视觉缺陷发生率为15.7%。
临床怎么用
- 伽玛刀可作为纳尔逊综合征的治疗选择,尤其适用于术后残留或复发患者。
- 治疗后需长期随访垂体功能,及时发现垂体功能减退并给予激素替代。
- 关注视力变化,新发视觉缺陷需评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Nelson's syndrome is a rare and challenging neuroendocrine disorder, and it is associated with elevated adrenocorticotrophic hormone (ACTH) level, skin hyperpigmentation, and pituitary adenoma growth. Management options including resection and medical therapy are traditional approaches. Ionizing radiation in the form of Gamma Knife radiosurgery (GKRS) is also being utilized to treat Nelson's syndrome. In the current study the authors sought to better define the therapeutic role of stereotactic radiosurgery (SRS) in Nelson's syndrome. METHODS: Study patients with Nelson's syndrome were treated with single-fraction GKRS (median margin dose of 25 Gy) at 6 different centers as part of an International Radiosurgery Research Foundation (IRRF) investigation. Data including neurological function, endocrine response, and radiological tumor response were collected and sent to the study-coordinating center for review. Fifty-one patients with median endocrine and radiological follow-ups of 91 and 80.5 months from GKRS, respectively, were analyzed for endocrine remission, tumor control, and neurological outcome. Statistical methods were used to identify prognostic factors for these endpoints. RESULTS: At last follow-up, radiological tumor control was achieved in 92.15% of patients. Endocrine remission off medical management and reduction in pre-SRS ACTH level were achieved in 29.4% and 62.7% of patients, respectively. Improved remission rates were associated with a shorter time interval between resection and GKRS (p = 0.039). Hypopituitarism was seen in 21.6% and new visual deficits were demonstrated in 15.7% of patients. CONCLUSIONS: GKRS affords a high rate of pituitary adenoma control and improvement in ACTH level for the majority of Nelson's syndrome patients. Hypopituitarism is the most common adverse effect from GKRS in Nelson's syndrome patients and warrants longitudinal follow-up for detection and endocrine replacement.
引用
- Cordeiro D, Xu Z, Li CE, et al. Gamma Knife radiosurgery for the treatment of Nelson's syndrome: a multicenter, international study. J Neurosurg. 2019. PMID: 31299652. doi:10.3171/2019.4.JNS19273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。